NASDAQ:FLXN
Delisted
Flexion Therapeutics Stock News
$9.12
+0 (+0%)
At Close: May 27, 2022
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Friday, 06'th Mar 2020
BURLINGTON, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to three new...
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 56'5(c)(4)
12:00am, Friday, 06'th Mar 2020Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
05:30pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (FLXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
05:30pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (FLXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flexion Therapeutics (FLXN) to Release Quarterly Earnings on Thursday
03:08pm, Thursday, 05'th Mar 2020
Flexion Therapeutics (NASDAQ:FLXN) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of ($1.00) p
Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know
12:00am, Thursday, 05'th Mar 2020Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020
09:30pm, Wednesday, 04'th Mar 2020
BURLINGTON, Mass., March 04, 2020 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and full-year 2019 financial results after.
Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020
09:30pm, Wednesday, 04'th Mar 2020
BURLINGTON, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth-quarter and...
Flexion Therapeutics to Report Fourth-Quarter and Full-Year —…–9 Financial Results on ...
12:00am, Wednesday, 04'th Mar 20203 High-Risk, High-Reward Stocks That Have Massive Upside Potential
12:25pm, Saturday, 29'th Feb 2020
If you can handle the uncertainty, these small-cap stocks can make you very wealthy.
Essex Investment Management Co. LLC Invests $414,000 in Flexion Therapeutics Inc (NASDAQ:FLXN)
12:24pm, Saturday, 29'th Feb 2020
Essex Investment Management Co. LLC purchased a new position in Flexion Therapeutics Inc (NASDAQ:FLXN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and E
Flexion Therapeutics Inc (NASDAQ:FLXN) Receives $25.88 Consensus PT from Brokerages
11:38am, Saturday, 29'th Feb 2020
Flexion Therapeutics Inc (NASDAQ:FLXN) has been given an average rating of “Buy” by the twelve ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has
Analysts' Opinions Are Mixed on These Healthcare Stocks: Harvard Bioscience (HBIO) and Tilray (TLRY)
06:33pm, Thursday, 27'th Feb 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harvard Bioscience (HBIO) and Tilray (TLRY). Harvard
